Yi Wenzhe, Hu Shuangshuang, Qian Xindi, Yan Wenlu, Li Yaping
State Key Laboratory of Drug Research and Center of Pharmaceutics Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai China.
University of Chinese Academy of Sciences Beijing China.
Exploration (Beijing). 2025 Jan 16;5(2):20240095. doi: 10.1002/EXP.20240095. eCollection 2025 Apr.
Although drug delivery technology has promoted the clinical translation of small molecule drugs, there is an urgent need for advanced delivery systems to overcome complex physiological barriers and the increasing development of biological drugs. This review overviews the emerging applications of synthetic biology-based engineered cells for drug delivery. We first introduce synthetic biology strategies to engineer cells for biological drug delivery and discuss the benefits in terms of specificity, intelligence, and controllability. Furthermore, we highlight the cutting-edge advancements at the convergence of synthetic biology and nanotechnology in drug delivery. Nanotechnology expands the engineering design and construction concepts of synthetic biology, and synthetic biology drives the development for biotechnology-driven nanomaterial synthesis. In the future, synthetic biology-based engineered cells may be developed to be more modular, standardized, and intelligent, leading to significant breakthroughs in the construction of advanced drug delivery systems.
尽管药物递送技术推动了小分子药物的临床转化,但仍迫切需要先进的递送系统来克服复杂的生理屏障以及生物药物不断增长的发展需求。本综述概述了基于合成生物学的工程细胞在药物递送方面的新兴应用。我们首先介绍用于生物药物递送的工程细胞的合成生物学策略,并从特异性、智能性和可控性方面讨论其优势。此外,我们强调了合成生物学与纳米技术在药物递送领域融合的前沿进展。纳米技术扩展了合成生物学的工程设计和构建概念,而合成生物学推动了生物技术驱动的纳米材料合成的发展。未来,基于合成生物学的工程细胞可能会发展得更具模块化、标准化和智能化,从而在先进药物递送系统的构建方面取得重大突破。